Ads

 

Ads

 

Ads

 

World Top 100 Biotechnology Companies List by Market Cap as of August 2026

World Top 100 Biotechnology Companies List by Market Cap as of August 2026, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as of August 2026.

Metatag Title
World Top Biotechnology Companies in 2026
Metatag Abstract
World Largest Biotechnology Companies by Market Cap in 2026, World Top Biotechnology Companies by Market Cap in 2026.
  1. uniQure N.V.

    World Rank (Aug-2026)
    4,693
    Market Cap (Aug-2026)
    3.373 Billion USD
    World Rank (Jan-05-2024)
    15,314
    Market Cap (Jan-05-2024)
    0.324 Billion USD
    World Rank (Jul-30-2023)
    13,144
    Market Cap (Jul-30-2023)
    0.469 Billion USD
    World Rank (Dec-25-2022)
    7,966
    Market Cap (Dec-25-2022)
    1.090 Billion USD
    World Rank (Jan-07-2022)
    9,983
    Market Cap (Jan-07-2022)
    0.90 Billion USD
    Annual Revenue in USD
    524 Million USD
    Annual Net Income in USD
    329 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Biotechnology company with headquarters is in Amsterdam, Netherlands.
  2. AbCellera Biologics Inc.

    World Rank (Aug-2026)
    4,707
    Market Cap (Aug-2026)
    3.353 Billion USD
    World Rank (Jan-05-2024)
    6,216
    Market Cap (Jan-05-2024)
    1.724 Billion USD
    World Rank (Jul-30-2023)
    5,362
    Market Cap (Jul-30-2023)
    2.220 Billion USD
    World Rank (Dec-25-2022)
    4,125
    Market Cap (Dec-25-2022)
    2.955 Billion USD
    World Rank (Jan-07-2022)
    4,491
    Market Cap (Jan-07-2022)
    3.33 Billion USD
    Annual Revenue in USD
    288 Million USD
    Annual Net Income in USD
    118 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    ABCELLERA BIOLOGICS INC. is Biotechnology sector company with headquarters is in Vancouver, Canada.
  3. CJ Corporation

    World Rank (Aug-2026)
    4,724
    Market Cap (Aug-2026)
    3.329 Billion USD
    World Rank (Jan-05-2024)
    5,675
    Market Cap (Jan-05-2024)
    2.007 Billion USD
    World Rank (Jul-30-2023)
    7,266
    Market Cap (Jul-30-2023)
    1.365 Billion USD
    World Rank (Dec-25-2022)
    5,956
    Market Cap (Dec-25-2022)
    1.733 Billion USD
    World Rank (Jan-07-2022)
    7,791
    Market Cap (Jan-07-2022)
    1.38 Billion USD
    Annual Revenue in USD
    25,794 Million USD
    Annual Net Income in USD
    206 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile

    CJ Group had businesses in 4 segments and they are

    • Food & Food Service
    • biotechnology
    • Logistics & New Distribution
    • Entertainment & Media

    Headquarters is in Seoul, South Korea.

  4. Veracyte

    World Rank (Aug-2026)
    4,732
    Market Cap (Aug-2026)
    3.316 Billion USD
    World Rank (Jan-05-2024)
    5,873
    Market Cap (Jan-05-2024)
    1.898 Billion USD
    World Rank (Jul-30-2023)
    5,673
    Market Cap (Jul-30-2023)
    2.035 Billion USD
    World Rank (Dec-25-2022)
    5,892
    Market Cap (Dec-25-2022)
    1.764 Billion USD
    World Rank (Jan-07-2022)
    5,608
    Market Cap (Jan-07-2022)
    2.39 Billion USD
    Annual Revenue in USD
    517 Million USD
    Annual Operating Income in USD
    58 Million USD
    Annual Net Income in USD
    66 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Veracyte is a Pioneering Genomic Diagnostics company. It's innovations in genomic technology and machine learning to enable more confident diagnostic, prognostic and treatment decisions in challenging diseases such as thyroid cancer, lung cancer, breast cancer and idiopathic pulmonary fibrosis. The headquarters is in USA.
  5. Celldex Therapeutics

    World Rank (Aug-2026)
    4,755
    Market Cap (Aug-2026)
    3.294 Billion USD
    World Rank (Jan-05-2024)
    5,438
    Market Cap (Jan-05-2024)
    2.151 Billion USD
    World Rank (Jul-30-2023)
    6,490
    Market Cap (Jul-30-2023)
    1.640 Billion USD
    World Rank (Dec-25-2022)
    5,323
    Market Cap (Dec-25-2022)
    2.078 Billion USD
    World Rank (Jan-07-2022)
    6,911
    Market Cap (Jan-07-2022)
    1.71 Billion USD
    Annual Revenue in USD
    2 Million USD
    Annual Operating Income in USD
    -287 Million USD
    Annual Net Income in USD
    -259 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Its pipeline includes immunotherapies and other targeted biologics derived from a broad set of complementary technologies which have the ability to engage the human immune system and/or directly inhibit tumors to treat specific types of cancer or other diseases. Headquarters is in USA.

  6. Arcutis Biotherapeutics Inc.

    World Rank (Aug-2026)
    4,757
    Market Cap (Aug-2026)
    3.292 Billion USD
    World Rank (Jan-05-2024)
    14,287
    Market Cap (Jan-05-2024)
    0.381 Billion USD
    World Rank (Jul-30-2023)
    10,942
    Market Cap (Jul-30-2023)
    0.667 Billion USD
    World Rank (Dec-25-2022)
    9,104
    Market Cap (Dec-25-2022)
    0.871 Billion USD
    World Rank (Jan-07-2022)
    9,768
    Market Cap (Jan-07-2022)
    0.94 Billion USD
    Annual Revenue in USD
    372 Million USD
    Annual Operating Income in USD
    -12 Million USD
    Annual Net Income in USD
    -16 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Arcutis Biotherapeutics is a Pioneering Medical Dermatology company dedicated to revolutionizing the treatment of serious skin diseases. It is focused on filling the innovation gap in medical dermatology drug development by applying deep clinical, product development and commercial expertise in dermatology to develop best in class therapies against biologically validated targets. It is having  29 employees as on 2019. The headquarters is in USA.
  7. Myovant Sciences

    World Rank (Aug-2026)
    4,776
    World Rank (Jan-05-2024)
    4,776
    World Rank (Jul-30-2023)
    4,776
    Market Cap (Jul-30-2023)
    2.620 Billion USD
    World Rank (Dec-25-2022)
    4,545
    Market Cap (Dec-25-2022)
    2.608 Billion USD
    World Rank (Jan-07-2022)
    8,121
    Market Cap (Jan-07-2022)
    1.29 Billion USD
    Annual Revenue in USD
    271 Million USD
    Annual Net Income in USD
    -241 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Company Profile

    Myovant Sciences is a biopharmaceutical company. It works for women and for men through purpose driven science, Empowering Medicines and Transformative Advocacy company. It have three clinical programs for relugolix which consisted of five international phase 3 clinical trials, two in women with heavy menstrual bleeding associated with uterine fibroids, two in women with endometriosis associated pain and one in men with advanced prostate cancer. The headquarters is in UK.

    Sumitovant Biopharma acquired Myovant Sciences for 1.7 billion USD in 2023.

  8. Synthorx

    World Rank (Aug-2026)
    4,777
    World Rank (Jan-05-2024)
    4,777
    World Rank (Jul-30-2023)
    4,777
    World Rank (Dec-25-2022)
    4,777
    World Rank (Jan-07-2022)
    4,777
    Headquarters Country
    Company Profile

    Synthorx is a Clinical Stage Biotechnology company. It is focused on prolonging and improving the lives of people with cancer and autoimmune disorders and platform technology expands the genetic code by adding a new DNA base pair and is designed to create optimized biologics referred to as Synthorins. The headquarters is in USA.

    Assore delisted from JSE in March-2020.

  9. Iovance Biotherapeutics

    World Rank (Aug-2026)
    4,887
    Market Cap (Aug-2026)
    3.162 Billion USD
    World Rank (Jan-05-2024)
    5,548
    Market Cap (Jan-05-2024)
    2.075 Billion USD
    World Rank (Jul-30-2023)
    6,175
    Market Cap (Jul-30-2023)
    1.782 Billion USD
    World Rank (Dec-25-2022)
    8,549
    Market Cap (Dec-25-2022)
    0.966 Billion USD
    World Rank (Jan-07-2022)
    5,413
    Market Cap (Jan-07-2022)
    2.55 Billion USD
    Annual Revenue in USD
    264 Million USD
    Annual Operating Income in USD
    -403 Million USD
    Annual Net Income in USD
    -391 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Iovance Biotherapeutics is a development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes company. The headquarters is in USA.
  10. Bioarctic AB (publ)

    World Rank (Aug-2026)
    4,905
    Market Cap (Aug-2026)
    3.144 Billion USD
    World Rank (Jan-05-2024)
    5,245
    Market Cap (Jan-05-2024)
    2.290 Billion USD
    World Rank (Jul-30-2023)
    5,000
    Market Cap (Jul-30-2023)
    2.461 Billion USD
    World Rank (Dec-25-2022)
    4,970
    Market Cap (Dec-25-2022)
    2.293 Billion USD
    World Rank (Jan-07-2022)
    8,941
    Market Cap (Jan-07-2022)
    1.09 Billion USD
    Annual Revenue in USD
    2 Million USD
    Annual Net Income in USD
    -11 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    BioArctic AB (publ) is a Swedish research based biopharma company focusing on disease modifying treatments and reliable biomarkers and diagnostics for neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease. The company annual revenue is 62.3 million SEK and total assets are 1,050 million SEK as on 2020. The headquarters is in Sweden.

Share

Ads